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We have engineered the ecdysone-inducible mammalian expres-
sion system for general retroviral delivery to cultured mammalian
cells. We inducibly expressed PTEN in the glioblastoma cell line,
U87MG, lacking this gene. Because nearly all cells are recruited on
induction, we find both up- and down-regulated genes by cDNA
microarray analysis. The changes we see are similar to those
observed after treatment with LY294002, an inhibitor of phospha-
tidylinositol 3-OH kinase, fully consistent with the model that PTEN
antagonizes phosphatidylinositol 3-OH kinase. Both treatments
result in suppressed expression of the transforming growth factor
(TGF)- gene and the genes of the cholesterol biosynthesis path-
way. Our results illustrate the power of using a fully inducible
expression system in conjunction with cDNA microarray analysis
for exploring gene function.
inducible expression  glioblastoma  DNA microarray
PTENMMAC1TEP1 is a tumor suppressor on 10q22–23that is found mutated in patients with Cowden’s disease and
in advanced cancers (1–5). PTEN was found to have sequence
similarity to protein tyrosine phosphatases (1, 2, 6). The phos-
phatase activity of the PTEN gene product was clearly apparent
only with highly negatively charged peptides poly(Glu-Tyr 4:1)
(7). This observation led to the pursuit of other nonproteina-
ceous substrates of PTEN. Indeed, PTEN was demonstrated to
have phosphoinositide-3-phosphatase activity capable of con-
verting products of phosphatidylinositol 3-OH (PI3)-kinase to
their unphosphorylated form at the D-3 position of the inositol
ring (8, 9). Furthermore, forced expression of PTEN in cultured
cells reduced the amount of phosphorylation of AKT-kinase, a
downstream target of PI3-kinase (9–11). Significantly, a single
germ-line mutation (G129E) in PTEN that caused loss of its lipid
phosphatase activity, but not its ability to dephosphorylate
poly(Glu-Tyr 4:1), was present in some Cowden’s disease kin-
dreds (9). This suggested that the main effect of loss of PTEN
results from the unbridled activity of PI3-kinase. We desired to
put this hypothesis to a more rigorous test by comparing the
consequences of forced expression of PTEN to the chemical
inhibition of PI3-kinase in a host lacking endogenous PTEN.
To conduct these experiments, we sought to use an inducible
rather than a constitutive expression system. The acute responses
of a host may be monitored by using inducible expression,
whereas the constitutive expression of some genes may be toxic
or deleterious to the host, leading to selection for tolerant
subpopulations of cells after prolonged expression of the gene in
the host. With constitutive expression systems, the gross over-
expression of a gene may result in nonphysiological responses. By
using inducible systems, in principle, levels of expression of the
transgene can be adjusted to be within physiological ranges.
Finally, the use of inducible systems allows the experimenter to
explore the response of the same host cell to two different
stimuli, thus controlling for clone-to-clone variability.
An ideal inducible system would have several features. First,
it would be tightly regulated, with no expression in the uninduced
state and a rapid inductive response. Second, there would be a
dose dependence between the inducer added and transgene
expression. Third, the components of the inducible system would
be inert with respect to the host. Fourth, the proportion of host
cells that respond when inducer is added (hereinafter referred to
as recruitment) would be high. This last requirement is partic-
ularly important in two cases: when studying genes that confer
growth disadvantage to the host cell, such as tumor suppressors;
and when performing transcriptional profiling studies, wherein
the presence of unresponsive cells would obscure the observation
of gene repression caused by induction of the transgene.
The two most widely used inducible mammalian systems use
tetracycline- or ecdysone-responsive transcriptional elements
(12, 13). The chief drawback of the tetracycline-inducible system
has been reported to be a relatively high background of expres-
sion in the uninduced state (12). The ecdysone-inducible system
was developed to address this issue. The ecdysone-inducible
system has a sensor that is made of two nuclear receptors
transcription factors [modified ecdysone receptor (VgEcR)
and retinoid X receptor (RXR)], which dimerize in the presence
of inducer and activate transcription of a gene of interest from
a cognate promoter. The gene of interest is placed under the
control of this promoter. In a typical protocol, the sensor
components are introduced by transfection into the cell line of
interest, stable ‘‘host’’ clones are established by antibiotic selec-
tion, and the hosts are tested individually for their ability to
induce a reporter gene introduced on a separate plasmid. A
successful host then serves as a recipient of the inducible gene
of interest (13).
In our experience, the existing methods for the construction
of inducible cell lines had two important shortcomings: they were
laborious, and the resulting inducible hosts showed considerable
clonal variegation. Clonal variegation, resulting in fewer than
50% of the cells in a clone responding to inducer (poor recruit-
ment), can be a significant obstacle to functional analysis. In this
work we address these two problems associated with the plasmid-
based systems. We have ameliorated the recruitment problem by
re-engineering the system for retroviral delivery, thus assuring a
more homogeneous expression of both sensor elements and
inducible transgene. We describe a general strategy that uses
fluorescence-activated cell sorting (FACS) to rapidly derive
inducible cell lines. To date we have generated hosts from three
human (U87MG, 293, and T47D) and two mouse cell lines (NIH
3T3 and NMuMG).
We illustrate the effectiveness of the system by the analysis of
the consequence of inducing PTEN expression in the glioblas-
toma host cell, U87MG, that lacks its own endogenous PTEN
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gene, and comparing that to the consequences of blocking
PI3-kinase with LY294002.
Materials and Methods
Cells and Cell Culture Methods. U87MG (human glioblastoma,
ATTC no. HTB-14) was maintained in 10% FBS in DMEM. NIH
3T3 (mouse embryo fibroblast, ATCC no. CRL-1658) cell line was
grow in 10% calf serum in DMEM. Other hosts were developed
from the following cell lines: (i) 293 (human embryonal kidney,
ATCC no. CRL-1573); (ii) T47D (human mammary gland ductal
carcinoma, ATCC no. HTB133); and (iii) NMuMG (mouse mam-
mary gland, ATCC no. CRL-1636). Retroviral-mediated gene
transfer into recipient cell lines was carried out according to Wang
et al. (14). Host cell lines expressing transgenes were maintained
with hygromycin selection at 50 g/ml. Muristerone A (Invitrogen)
was reconstituted in absolute ethanol before adding to cells for
induction. An equal amount of ethanol was added to plates that
were uninduced.
Retroviral Vector Constructions. The nuclear receptorstranscrip-
tion factors RXR and VgEcR (Invitrogen) were cloned in
pMAO Neo and pMAO Puro, respectively. RXR was amplified
by PCR that used primers coding for EcoRI on the 5 end and
XhoI at the 3 end and inserted as an EcoRI–XhoI fragment into
pMAONeo, yielding RXR-pMAONeo (pRXR-MN). VgEcR
was amplified with primers coding for EcoRI on both ends and
inserted as an EcoRI fragment in pMAOPuro, yielding VgEcR-
pMAOPuro (pVgEcR-MP). The MAO retroviruses are similar
to the pBabe type of Moloney murine leukemia virus (MoMLV)
retroviral vectors, but also carry the simian virus 40 origin of
replication in the nonviral part of their backbone. The receptor-
coding sequences were placed downstream of the 5 long ter-
minal repeat (LTR) promoters; the antibiotic resistance markers
were placed downstream of PGK promoters as HindIII–ClaI
inserts. Both transcripts terminated in the 3 LTR poly(A) signal.
pI-TKHygro is a derivative of pSin (courtesy of David Beach),
a self-inactivating retrovirus that lacks U3 enhancers in the 3
LTR. The hybrid ecdysone response element (EGRE) and
polylinker (MCS) from pIND (Invitrogen) were amplified with
BamHI–XhoI primers and cloned downstream of pSin’s 5LTR
as an BglIIBamHI–XhoI fragment. This virus also carries a
thymidine kinase enhancerless promoter (TKp) and the hygro-
mycin-resistance gene (HYG) cassette as an XhoI–ClaI fragment
between the polylinker and the 3 LTR. The transcript orienta-
tion and structure are the same as for the MAO vectors with one
important distinction, namely, the 3 LTR carries a deletion of
the U3 enhancers. On proviral integration, this deletion flanks
the retroviral insert thereby removing the enhancers from both
the 5 and the 3 LTRs. Therefore, the immediate vicinity of the
glucocorticoid response elements is transcriptionally silent and
assures tight induction control of the gene of interest. The
pI-TKHygro is the parent vector for pI-EGFP, pI-LacZ and all
PTEN inducible transgenes.
pI-LacZ was derived by subcloning LacZ into the polylinker
of pI-TKHygro as an HindII–XhoI fragment.
pI-EGFP is a derivative of pI-TKHygro that has the TK-Hygro
cassette deleted and the enhanced green fluorescent protein
(EGFP; CLONTECH) reporter inserted as an EcoRI–SalI
fragment.
Microscopy and Flow Cytometry. -Galactosidase expression was
visualized by fixing cells in 0.5% glutaraldehyde, washing the
cells, and then overlaying the cells with X-gal solution [0.2%
X-Gal2 mM MgCl25 mM K4Fe(CN)65 mM K3Fe(CN)6].
After sufficient blue color had developed, cells were washed and
kept in PBS. Photographs of cells were taken with the Zeiss
Axiovert 405 M fluorescence microscope with digital imaging
capabilities. Cells were sorted by using the Coulter Elite ESP
flow cytometer and carried out as described (15).
cDNA Microarray Analysis. mRNA isolations were carried out
according to the Poly(A) Pure kit (Ambion) protocol. Conver-
sion of mRNA to double-stranded cDNA was performed by
using the superscript cDNA synthesis kit (GIBCOBRL) ac-
cording to its protocol. High complexity representations (HCRs)
of each sample were then prepared according to a protocol
adapted from Lucito et al. (16). cDNA (400 ng) was digested with
DpnII (four base-restriction endonucleases) for 8 h at 37°C.
After phenolchloroform extraction, the digested cDNA was
precipitated by using 20 g glycogen, 3 M sodium acetate, and
absolute ethanol, then washed, resuspended, and ligated to the
cohesive adaptor RBgl24 and RBgl12 (see Lucito et al., ref. 16).
Primers complementary to adaptors were used to amplify de-
sired amounts of amplicons for microarray hybridizations.
A set of 14,000 human cDNA clones from the IMAGE
consortium (purchased from Research Genetics, Huntsville, AL,
and Invitrogen) were PCR amplified, purified, and robotically
spotted on glass slides as described by Schena et al. (17). cDNA
representations were labeled with fluorescent dyes (Cy3 or Cy5)
by using the random priming method (http:nucleus.
cshl.orgwigler). Arrays were processed and hybridized ac-
cording to protocols available on our web site (http:nucleus.
cshl.orgwigler).
After hybridization with samples labeled with Cy3 and Cy5,
the arrays were scanned to measure fluorescence by using a
GenePix 4000 laser scanner (Axon Instruments, Foster City,
CA). Raw data files generated by the scanner software GENEPIX3
were imported into S-Plus (a mathematicalstatistical package
from StatSci Division, Mathsoft, Cambridge, MA) for analysis.
For normalization, features for which R2 values were above 0.4,
and 50% of feature pixels were 1 SD above background pixels in
both channels, were considered. The data points were then
median normalized and plotted. Experiments were performed in
duplicate and color reversals (four hybridizations per sample
pair).
RNase Protection Assays. Total RNA was harvested from samples
of induced and uninduced U87MG expressing wild-type PTEN,
mutant PTEN, and LacZ. All RNase protection experiments
were performed by using the RPA III kit from Ambion following
the manufacturer’s instructions.
Results
Retroviral-Based Ecdysone-Inducible System. We placed the two
receptors (VgEcR and RXR) on separate MoMLV-based vi-
ruses, expressed off the 5 LTR (18, 19). Each receptor virus was
marked with a different antibiotic resistance—puromycin for
VgEcR and neomycin (G418) for RXR (Fig. 1). The gene of
interest was introduced into a self-inactivating MoMLV-based
retrovirus (I-TK-HYG), in which enhancers in the U3 region in
the 3  LTR are deleted so that, on proviral integration, no
enhancers remain (20). This virus was marked with HYG, driven
by a thymidine kinase enhancerless promoter (TKp). The gene
of interest is subcloned into the multiple cloning site, which lies
just downstream of the inducible cognate promoter
(EGREHsmin). We produced amphotropic viruses by using
high-titer packaging lines that were derived by Beach and
Hannon (14).
Typically, the recipient cells were transduced with both re-
ceptor viruses in the same infection and selected for both
puromycin and G418 resistance. Doubly resistant cell clones
were isolated, expanded and tested for their ability to serve as a
good ‘‘host.’’ To this end, each prospective host was infected with
a -galactosidase inducible virus, pI-LacZ (Fig. 1), which carries
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the HYG marker. Colonies were then selected for hygromycin
resistance.
For each prospective host we determined the proportion of the
hygromycin-resistant colonies that expressed any -galactosi-
dase on addition of inducer and the percentage of individual cells
in each colony that express -galactosidase. Thus we estimated
how many clones expressing the gene of interest one needs to
isolate to obtain, with high probability, a well-behaved inducible
clone. Once a good host was established, it served as a recipient
of the gene(s) of interest.
Our first experiments were performed with U87MG, a human
glioblastoma cell line lacking endogenous PTEN. After double
infection with receptor viruses (see Materials and Methods), and
double selection, five candidate host clones were selected based
on antibiotic resistance. They were infected with a -galactosi-
dase-inducible virus, split into two dishes at low density, and then
hygromycin resistance was selected, resulting in 200 colonies
per plate. One dish was induced with 0.5 M muristerone A, an
ecdysone analog, for 24 h and stained for -galactosidase, and
the proportion of blue colonies was determined. The second dish
remained uninduced and was stained to determine background.
For five of five host clones, all hygromycin resistant colonies
were inducible (Fig. 2A Lower), and none showed detectable
background (Fig. 2A Upper).
One of the five hosts, U87.23 was selected to document the
proportion of individual cells responding to inducer. To this end,
individual hygromycin-resistant colonies were isolated, ex-
panded, and plated onto coverslips for induction. Seven of seven
colonies had greater than 99% inducibility after only 8 h in 0.5
M muristerone A (Fig. 2B Lower Left). There was no detectable
background (Fig. 2B Upper Left). Cells induced for 12 and 24 h
displayed uniformly intense staining (Fig. 2B Lower Right and
Upper Right, respectively). Liquid -galactosidase activity assays
demonstrated that the background -galactosidase levels in the
uninduced cell line were equal, within standard error, to the
levels in the parental, nontransduced cell line (data not shown).
Full induction was achieved with 1.0 M muristerone A and was
at least 200-fold above background.
The process of obtaining good inducible hosts for other cell
lines was more laborious. Therefore, we modified the process for
finding a good host by using sorting to select suitable hosts out
of a large cell population. Cells were infected with three viruses:
VgEcR-MP; RXR-MN, and GFP-Sin (Fig. 1). GFP-Sin is a
self-inactivating virus identical to pI-TKHygro, but lacking the
hygromycin-resistance marker and carrying ecdysone-responsive
GFP. Cells expressing GFP in the absence of inducer are then
removed by FACS. The remaining cells were expanded and
induced with a very low dose of muristerone A (0.05 M-0.2
M). The top 1% of GFP-positive cells were collected. This step
can be repeated if necessary to enrich for robustly inducing cells.
Cells are plated for colony formation, induced, and examined for
GFP fluorescence. Those showing full recruitment at the single-
cell level were isolated, expanded, retested for inducibility, and
used as hosts.
We tested this protocol with three cell lines: U87MG, NIH
3T3, and 293. To demonstrate that the inducible hosts produced
by the FACS method can successfully serve as recipients of
another inducible transgene, we infected several of the GFP-
inducible hosts with pI-LacZ, then selected and isolated single
clones. These clones were examined for their ability to induce
both the GFP and the LacZ transgenes. Virtually all clones had
95% or better recruitment for inducible LacZ expression and
fully retained their inducibility for GFP expression.
Effects of PTEN Induction on Growth, Morphology, and Transcription
in U87MG Cells. We sought to study the consequence of restoring
PTEN in U87MG cells by using the inducible host, U87.23.
To this end, the following host cell lines were generated:
(i) U87.PTEN.WT, expressing wild-type PTEN; (ii)
U87.PTEN.G129E, expressing the lipid phosphatase-defective
mutant PTEN(G129E); (iii) U87.PTEN.G129R, expressing the
catalytically inactive mutant PTEN(G129R); and (iv) U87.LacZ,
expressing -galactosidase.
Fig. 1. Vector descriptions. pVgEcR-MP, retroviral vector for constitutive
expression of a modified Drosophila ecdysone receptor (containing the VP16
transactivation domain) from the LTR and marked with the puromycin-
resistance gene; pRXR-MN, retroviral vector for constitutive expression of the
RXR from the LTR and marked with the neomycin (G418)-resistance gene;
pI-TK Hygro, self-inactivating retroviral ecdysone-inducible vector marked
with HYG; pI-GFPsin, same vector as pI-TK Hygro but without hygromycin-
selectable marker; pI-LacZ: pI-TK Hygro containing the -galactosidase gene.
U3-R-U5, LTR; gag, envelope gene; VgEcR, ecdysone receptor; PGK, phospho-
glucokinase promoter; TKp, enhancerless thymidine kinase promoter; EGRE,
hybrid ecdysone response element (5); Hsmin, minimal heat shock promoter;
PURO, puromycin resistance gene; NEO, G418 resistance gene; MCS, multiple
cloning site; GFP, green flourescent protein; LacZ, -galactosidase gene.
Fig. 2. (A) The retroviral ecdysone-inducible system yields virtually 100%
inducible clones. Depiction of one of five candidate U87MG-inducible host
clones, U87.23, infected with pI-LacZ and selected for hygromycin-resistant
colonies. Each plate contained 200 colonies. The bottom dish was induced
with 0.5 M muristerone A for 24 h, fixed, and stained for -galactosidase
protein. The top dish was left uninduced, fixed, and also stained. Efficiency of
LacZ expression was comparable for the remaining four clonal hosts (data not
shown). (B) Complete recruitment by inducer at the single-cell level. The same
U87.23 LacZ-inducible cell line was plated on coverslips and induced with 0.5
mM muristerone A. Cells were fixed and stained for -galactosidase after 8 h
(Lower Left), 12 h (Lower Right) and 24 h (Upper Right), or left uninduced
(Upper Left). Note that even as early as 8 h all cells are recruited to express the
inducible transgene.
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To ascertain the level of induction of PTEN, U87.PTEN.WT
was induced with a range of concentrations (0.1 M to 1.5 M),
and induced PTEN expression was compared with expression in
HeLa and 293T cell lines by Western analysis (Fig. 3A). Inducer
(0.5 M) was sufficient to attain near physiological levels of
PTEN expression (Fig. 3A, compare lane 7 to lanes 19 and 20).
All of the other PTEN-expressing lines were also verified to be
inducible by Western analysis.
To assess the effect of PTEN on growth, we performed 4-day
growth curves on U87.PTEN.WT, U87.PTEN.G129E, and
U87.LacZ (negative control). Cells were grown in 2% FBS, with
or without muristerone A at 0.5 M. The induction of wild-type
PTEN does not affect growth in U87MG cells when compared
with induction of LacZ or PTEN(G129E) (data not shown). In
addition, we have carried out the experiment at serum concen-
trations ranging from 0.5% to 10% FBS and by using both mass
cultures and multiple independent clonal lines with consistent
results.
Cells were examined for effects of PTEN induction on their
morphology. Cell lines U87.PTEN.WT, U87.PTEN.G129E, and
U87.PTEN.G129R were induced with 0.5 M muristerone A.
When grown in 2% FBS, uninduced cells appeared weakly
attached to the plastic substrate and grew in a reticular forma-
tion. In the presence of inducer, the cultures expressing wild-type
PTEN were flat and more adherent (Fig. 3B). Induction of
G129E and the G129R mutant (data not shown) had no effect
on morphology. All cultures were verified to be inducible by
Western blotting (data not shown).
To establish whether the morphological effect was mediated
by phosphatidylinositide-3, 4,5 phosphate (PIP3), we incubated
U87.PTEN.WT cells with 10 M LY294002, an inhibitor of
PI3-kinase. This treatment produced a morphological change
indistinguishable from the one caused by expression of PTEN
(Fig. 3B), consistent with the hypothesis that the lipid phospha-
tase activity of PTEN is responsible for this phenotype.
To pursue further the similarities between PTEN induction
and inhibition of the PI3-kinase pathway, we examined the
transcriptional profiles of these two treatments by hybridization
to cDNA microarrays. To generate fluorescently tagged samples
for hybridization, we used high-complexity representations of
cDNAs. The protocol for preparing cDNA representations is
described in Materials and Methods. We prefer using cDNA
representations over first-strand cDNA samples for hybridiza-
tion to cDNA microarrays for two reasons: first, large amounts
of DNA can be prepared from small amounts of biological
samples; second, the resulting cDNA representations can be
readily analyzed by Southern blotting for a probe of interest to
confirm observations from the microarray data. To prove the
validity of this method, we have shown by array hybridization
experiments that the relative abundance of individual messages
in the initial mRNA are preserved in the final cDNA represen-
tation (22).
We have shown hybridizations by using cDNA representations
prepared from six sources: (i) U87.PTEN.WT untreated; (ii)
U87.PTEN.WT treated with muristerone A to induce expression
of wild-type PTEN; (iii) U87.PTEN.WT treated with LY294002;
(iv) U87.PTEN.G129R untreated; (v) U87.PTEN.G129R
treated with muristerone A to induce expression of the phos-
phatase defective mutant PTEN; and (vi) U87.PTEN.G129R
treated with LY294002. We then performed a series of two-way,
then four-way comparisons. For these comparisons, we estab-
lished the ratio of hybridization intensities from cDNA of two
sources.
To compare PTEN expression and LY294002 treatment, we
graphed the ratios obtained from U87.PTEN.WT treated with
muristerone A or untreated with the ratios of U87.PTEN.WT
treated with LY294002 or untreated. We observed a striking
correlation in the transcriptional profiles (Fig. 4A Left). This
effect was specific to the expression of wild-type PTEN, because
ratios of U87.PTEN.G129R treated or untreated with muris-
terone A did not show any similarity to ratios of the same cells
treated with LY294002 or untreated (Fig. 4A Center). Never-
theless, LY294002 induce similar changes in expression patterns
in both U87.PTEN.WT and U87.PTEN.G129R cells (Fig. 4A
Right).
Microarray hybridization experiments are often plagued by
‘‘system noise’’ that generates variability. It is necessary to
estimate variability to correctly interpret array data. To measure
the extent of variability for each sample, we performed a
‘‘self-to-self’’ hybridization, where each sample was labeled
separately with Cy3 and Cy5 and hybridized. Ideally the ratio of
Cy3 to Cy5 for all probes would be 1. In our self-to-self
experiments, we observed scatter about the ratio of 1, with very
few ratios observed to be 2. Table 1 lists genes that over
multiple experiments showed a 2-fold change when cells were
induced to express PTEN and when cells were treated with
LY294002. The expression of these genes were not altered when
mutant PTEN was induced. It is significant that we saw down-
Fig. 3. (A) Dose–response of PTEN-inducible line to muristerone A. Western
blot analysis of dose–response for cell line, U87.23.WT, expressing hemagglu-
tinin-tagged wild-type PTEN. Cells were induced with doses of muristerone A,
in increments of 0.1 M, from 0 (lane 2), to 1.5 M (lane 17), for 30 h. For
comparisons, lane 1 shows a cell line with inducible -galactosidase (negative
control) treated with 1.5 M muristerone A, and lanes 19 and 20 show
endogenous levels of PTEN in two PTEN-positive human cell lines, 293T, and
HeLa respectively. The filter was probed by using anti-PTEN C terminus anti-
bodies. Background expression is undetectable, even after very long expo-
sures, and maximal expression is perhaps only a few fold elevated over
endogenous levels. (B) PTEN and LY alter the cell growth pattern of U87MG
cells in low serum in a similar fashion. U87MG cells carrying wild-type or
mutant (G129E) inducible PTEN were seeded in 2% FBS DMEM at high density
and either induced to express PTEN with 0.5 mM muristerone A (Upper Left
and Upper Center), or left uninduced (Lower Left and Lower Center panels).
U87MG cells were treated with 10 M LY294002 for 24 h (Upper Right)
or untreated (Lower Right). Nomarski photographs were taken 24 h after
induction.
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regulated genes after induction of PTEN, because this is only
possible with robust recruitment by our inducible system.
To investigate the reliability of the array data we used two
techniques on several probes: Southern blots of cDNA repre-
sentations and RNase protection assays (RPA) on total RNA. A
representative RPA analysis of two genes, HMG-CoA synthase
and HMG-CoA reductase, are shown in Fig. 4B. Both genes are
suppressed on induction of wild-type PTEN and on treatment
with LY294002. There was good correlation between these
methods and the array data.
Fig. 4. (A) Induction of PTEN and treatment with LY294002 affect a similar set of transcriptional targets. U87MG cell lines carrying inducible wild-type
(U87.PTEN.WT) or mutant (U87.PTEN.G129R) PTEN were induced with 0.5 M muristerone A for 36 h or treated with LY294002 for the same amount of time.
mRNAs were isolated, converted to double-stranded cDNA. cDNAs were amplified to generate HCRs, labeled with fluorescent dyes, and hybridized to human
cDNA microarrays carrying 14,000 probes. The normalized fluorescent ratios for individual array features were computed and then graphed. Scatter plots depict
comparison of normalized ratios: U87.PTEN.WT treated () or untreated () with muristerone A versus the same cells treated or untreated with LY294002 (Left);
U87.PTEN.G129R treated or untreated with muristerone A versus the same cells treated or untreated with LY294002 (Center); U87.PTEN.WT treated or untreated
with LY294002 versus U87.PTEN.G129R treated or untreated with LY294002 (Right). Values on the axes are positive for ratios greater than 1 or negative
reciprocals for ratios less than 1. The positive and negative signs represent induction or repression of gene expression, respectively. (B) RNase protection of HMG
CoA reductase and HMG CoA synthase transcripts. U87MG cells carrying inducible PTEN were either induced with muristerone (lanes 1 and 4) or uninduced (lanes
2 and 5). Control (c) represents reactions carried out without total RNA (lanes 3 and 6). Total RNA was isolated and subjected to RNase protection assay by using
anti-sense 32P-labeled probes representing the genes shown above the panel. Protected probes were purified and separated on a polyacrylamide gel as described
in Sambrook et al. (21). GAPDH (glyceraldehyde-3-phosphate dehydrogenase) mRNA was used as a control to check integrity of mRNAs in the sample and to
normalize gene-specific signal.
Table 1. Differentially expressed genes under conditions of wild-type PTEN induction and inhibition by LY294002
Gene name Accession no. WT LY Description
Down-regulated by treatment
Stathmin AA873060 4.8 3.5 Phosphoprotein. Cell proliferation and differentiation
Transforming growth factor -1 R36467 3.1 3.9 Cell proliferation and differentiation
ADP-ribosylation factor-4 T71316 4.0 4.0 GTP binding protein, activator of phospholipase
ADP-ribosylation factor-like 1 N51280 2.8 5.0 GTP binding protein
HMG-CoA synthase X83618 3.5 4.7 Cholesterol synthesis
HMG-CoA reductase AI038284 2.5 2.7 Cholesterol synthesis
Squalene synthase AA018779 2.6 4.0 Cholesterol synthesis
Human homolog of yeast IPP isomerase H08899 2.3 3.1 Cholesterol synthesis
Homo sapiens mRNA for epiregulin N31585 2.7 3.0 Epidermal growth factor; tumor growth-inhibitory factor
Interferon-related developmental regulator 1 AA676598 3.0 2.8 Muscle differentiation and signal transduction
Cytochrome C R52654 2.5 3.3 Mediates the electron transfer
H. sapiens mRNA for TFG protein R60846 2.4 2.3 Transmembrane receptor tyrosine kinase protooncogene
ER lumen protein retaining receptor 2 AA626867 2.5 3.7 Sorting of proteins
Adrenergic, beta-2, receptor H90431 2.4 3.2 Transmembrane G protein-coupled receptor
Homo sapiens insulin induced protein H59620 2.5 3.4 Growth response
Glycyl-tRNA synthetase AA629909 2.6 5.0 Protein translation
Alanyl-tRNA synthetase AA156571 3.2 5.7 Protein translation
Up-regulated by treatment
Cartilage glycoprotein-39 precursor AA434115 3.5 3.2 Deposition and remodeling of cartilage matrix
Human sigma receptor mRNA, comp W47484 3.8 3.1 Interaction with antipsychotic drugs; involved in psychiatric disorders
ESTs, highly similar to J KAPPA R19314 2.8 3.2 Recombination signal binding protein
Fibronectin 1 N26285 4.2 2.4 Cell adhesion, morphology and surface architecture
Lactate dehydrogenase A AA48961 3.2 2.6 Converts L-lactate to pyruvate during anaerobic glycolysis
Genes that consistently show similar patterns of expression on PTEN induction or LY294002 treatment and not on induction of mutant PTEN (G129R) are
tabulated. Values in the WT (induction of wild-type PTEN) and LY (treatment with LY294002) columns denote fold changes in expression. A negative value is
assigned for repression and a positive value is assigned for induction. Accession nos. are from GenBank. Descriptions of genes are from National Center for
Biotechnology Information databases.
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Discussion
We have developed and used an ecdysone-inducible gene ex-
pression system that utilizes retroviral delivery. The system
appears to be close to ideal in many respects. It is relatively easy
to create hosts. Gene induction is rapid and can be controlled in
a dose-dependent manner, allowing us to study expression of a
gene at physiological levels. There is negligible expression in the
absence of inducer, which decreases the risk of acquisition of
tolerance by the host. Recruitment of expression, that is the
percentage of host cells that respond to inducer, is very high, as
judged both by -galactosidase and GFP expression studies. This
conclusion is further strengthened by our transcriptional profil-
ing, in which we observe both up-regulation and down-regulation
of gene expression after addition of inducer. The down-
regulation of gene expression consequent to induction of PTEN
would not be observable were PTEN not induced in the great
majority of cells.
In an ideal system, the inducer should be inert. Muristerone
A is nearly inert, having no effects on cellular morphology or
gene transcription that we have observed. However, the addition
of muristerone leads to a slight inhibition of cell growth. This is
not an intrinsic feature of the activation of the ecdysone receptor,
because addition of muristerone to U87MG cells that lack the
responsive system still results in slightly slower growth.
Our results show absence of growth effect of PTEN induction
on U87MG cells. This observation is in marked contrast to the
6-fold increase in the length of the cell cycle observed by the
group of Hong Sun (10). We think that this difference may be
because of the expression of higher and nonphysiological levels
of PTEN from the constitutive retroviral system used by Sun et
al. (see figure 1C of that paper). It is our contention that our
inducible U87MG cell line experiments carry more weight,
because of the controlled PTEN expression. Moreover, it seems
unlikely to us that physiological levels of PTEN inhibit the cell
cycle severely because PTEN expression is found ubiquitously in
proliferating cell lines and tissues.
The combination of inducible systems with transcriptional
profiling is especially powerful. The analysis of PTEN expression
in U87MG cells confirms the major hypothesis of PTEN action,
that its effects result from its PIP3 phosphatase activity. The
addition of an inhibitor of PI3-kinase, LY294002, produces a
change in the transcriptional profile of U87MG that is very
similar to that produced by the induction of wild-type PTEN.
Induction of the PTEN(G129R) mutant, which is catalytically
inert, does not produce these changes. Our arrays do not,
however, contain all of the transcription units of the cell, so
major differences may have been missed.
The transcriptional profiling did produce some unexpected
findings. First, the genes of the cholesterol biosynthesis pathway,
namely HMG-CoA synthase, squalene synthase, and HMG-CoA
reductase were down-regulated by PTEN and LY294002. If
generally true, this would suggest that certain hormones and
growth factors, such as insulin, that activate the PI3-kinase
pathway, may also increase cholesterol biosynthesis. We have not
seen this connection made in the literature. Second, one of the
most strongly down-regulated genes, by both LY294002 and
PTEN, was transforming growth factor (TGF)  (Table 1).
Interestingly, TGF- is known to down-regulate PTEN (6). Thus
there appears to be a mutual antagonism of these two genes.
Transcriptional profiling of the response of cells to a stimulus
does not distinguish primary from secondary responses. It is
possible, for example, that the wide-ranging similarity of PTEN
induction and LY294002 treatment results from the secondary
response of cells to down-regulation of TGF-. Additional
experiments would be needed to resolve this question.
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